News
10-31-2008, 09:30 AM
Researchers at Georgetown University Medical Center have discovered a novel way in which breast cancer cells become resistant to tamoxifen, the world's largest-selling breast cancer prevention and treatment drug. They say the findings could provide a way to identify tamoxifen users who are no longer benefiting from the drug, allowing doctors to try another therapy option sooner.
More... (http://www.medicalnewstoday.com/articles/127715.php)
More... (http://www.medicalnewstoday.com/articles/127715.php)